Randomized trial comparing suture button with single 3.5 mm syndesmotic screw for ankle syndesmosis injury: similar results at 2 years
DOI:
https://doi.org/10.1080/17453674.2020.1818175Abstract
Background and purpose — Better outcomes are reported for suture button (SB) compared with syndesmotic screws (SS) in patients treated for an acute ankle syndes- motic injury. One reason could be that screws are more rigid than an SB. A single tricortical 3.5 mm syndesmotic screw (TS) is the most dynamic screw option. Our hypothesis is that 1 SB and 1 TS provide similar results. Therefore, in ran- domized controlled trial, we compared the results between SB and TS for syndesmotic stabilization in patients with acute syndesmosis injury.
Patients and methods — 113 patients with acute syn- desmotic injury were randomized to SB (n = 55) or TS (n = 58). The American Orthopedic Foot & Ankle Society (AOFAS) Ankle–Hindfoot Score was the primary outcome measure. Secondary outcome measures included Manches- ter Oxford Foot Questionnaire (MOXFQ), Olerud–Molan- der Ankle score (OMA), visual analogue scale (VAS), EuroQol- 5D (EQ-5D), radiologic results, range of motion, complications, and reoperations (no implants were routinely removed). CT scans of both ankles were obtained after sur- gery, and after 1 and 2 years.
Results — The 2-year follow-up rate was 84%. At 2 years, median AOFAS score was 97 in both groups (IQR SB 87–100, IQR TS 90–100, p = 0.7), median MOXFQ index was 5 in the SB group and 3 in the TS group (IQR 0–18 vs. 0–8, p = 0.2), and median OMA score was 90 in the SB group and 100 in the TS group (IQR 75–100 vs. 83–100, p = 0.2). The syndesmotic reduction was similar 2 years after surgery; 19/55 patients in the SB group and 13/58 in the TS group had a difference in anterior syndesmotic width ≥ 2 mm (p = 0.3). 0 patients in the SB group and 5 patients in the TS group had complete tibiofibular synostosis (p = 0.03). At 2 years, 10 TS were broken. Complications and reoperations were similar between the groups.
Interpretation — We found no clinically relevant differ- ences regarding outcome scores between the groups. TS is an inexpensive alternative to SB.
Downloads
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Benedikte Wendt Ræder, Ingrid Kvello Stake, Jan Erik Madsen, Frede Frihagen , Silje Berild Jacobsen, Mette Renate Andersen, Wender Figved
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.